BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18712761)

  • 21. Semi-parametric inferences for association with semi-competing risks data.
    Ghosh D
    Stat Med; 2006 Jun; 25(12):2059-70. PubMed ID: 16196081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical analysis of joint short-term and long-term survival in resuscitation research.
    Babbs CF
    Resuscitation; 2007 Nov; 75(2):323-31. PubMed ID: 17583410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. REML estimation of variance parameters in nonlinear mixed effects models using the SAEM algorithm.
    Meza C; Jaffrézic F; Foulley JL
    Biom J; 2007 Dec; 49(6):876-88. PubMed ID: 17638294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mixed-effects regression model for three-level ordinal response data.
    Raman R; Hedeker D
    Stat Med; 2005 Nov; 24(21):3331-45. PubMed ID: 16206246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Monte Carlo EM algorithm for generalized linear mixed models with flexible random effects distribution.
    Chen J; Zhang D; Davidian M
    Biostatistics; 2002 Sep; 3(3):347-60. PubMed ID: 12933602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dynamic frailty model for multivariate survival data.
    Yue H; Chan KS
    Biometrics; 1997 Sep; 53(3):785-93. PubMed ID: 9333346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimum Hellinger distance estimation for k-component poisson mixture with random effects.
    Xiang L; Yau KK; Van Hui Y; Lee AH
    Biometrics; 2008 Jun; 64(2):508-18. PubMed ID: 17970817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternity length of stay modelling by gamma mixture regression with random effects.
    Lee AH; Wang K; Yau KK; McLachlan GJ; Ng SK
    Biom J; 2007 Aug; 49(5):750-64. PubMed ID: 17722201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
    Wahed AS; Tsiatis AA
    Biometrics; 2004 Mar; 60(1):124-33. PubMed ID: 15032782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling clustered survival data from multicentre clinical trials.
    Glidden DV; Vittinghoff E
    Stat Med; 2004 Feb; 23(3):369-88. PubMed ID: 14748034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling bivariate count series with excess zeros.
    Lee AH; Wang K; Yau KK; Carrivick PJ; Stevenson MR
    Math Biosci; 2005 Aug; 196(2):226-37. PubMed ID: 16024052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analyzing survival curves at a fixed point in time.
    Klein JP; Logan B; Harhoff M; Andersen PK
    Stat Med; 2007 Oct; 26(24):4505-19. PubMed ID: 17348080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variance estimation for clustered recurrent event data with a small number of clusters.
    Schaubel DE
    Stat Med; 2005 Oct; 24(19):3037-51. PubMed ID: 16149126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring.
    Cook RJ; Lawless JF; Lee KA
    Stat Med; 2010 Mar; 29(6):694-707. PubMed ID: 20146240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
    Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
    J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx.
    Röösli C; Tschudi DC; Studer G; Braun J; Stoeckli SJ
    Laryngoscope; 2009 Mar; 119(3):534-40. PubMed ID: 19235752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimation of the treatment difference in multicenter trials.
    Fedorov V; Jones B; Jones M; Zhigljavsky A
    J Biopharm Stat; 2004 Nov; 14(4):1037-63. PubMed ID: 15587979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parametric accelerated failure time models with random effects and an application to kidney transplant survival.
    Lambert P; Collett D; Kimber A; Johnson R
    Stat Med; 2004 Oct; 23(20):3177-92. PubMed ID: 15449337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.